Proteins > Retinoic acid receptor RXR-alpha
Page last updated: 2024-08-07 16:07:59
Retinoic acid receptor RXR-alpha
A retinoic acid receptor RXR-alpha that is encoded in the genome of human. [PRO:DNx, UniProtKB:P19793]
Synonyms
Nuclear receptor subfamily 2 group B member 1;
Retinoid X receptor alpha
Research
Bioassay Publications (75)
Timeframe | Studies on this Protein(%) | All Drugs % |
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 16 (21.33) | 18.2507 |
2000's | 16 (21.33) | 29.6817 |
2010's | 33 (44.00) | 24.3611 |
2020's | 10 (13.33) | 2.80 |
Compounds (48)
Drugs with Inhibition Measurements
Drugs with Activation Measurements
Drug | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Publication(s) |
domperidone | Homo sapiens (human) | Kd | 8.8000 | 1 | 1 |
lg 100268 | Homo sapiens (human) | EC50 | 0.0220 | 5 | 5 |
lg 100268 | Homo sapiens (human) | Kd | 0.0030 | 1 | 1 |
oxaprozin | Homo sapiens (human) | EC50 | 16.1000 | 1 | 1 |
pirinixic acid | Homo sapiens (human) | EC50 | 9.1000 | 1 | 1 |
pirinixic acid | Homo sapiens (human) | Kd | 1.2800 | 1 | 1 |
3,3',5-triiodothyroacetic acid | Homo sapiens (human) | EC50 | 12.0000 | 1 | 1 |
3,3',5-triiodothyroacetic acid | Homo sapiens (human) | Kd | 1.3200 | 1 | 1 |
thyroxine | Homo sapiens (human) | EC50 | 15.4000 | 1 | 1 |
thyroxine | Homo sapiens (human) | Kd | 0.9300 | 1 | 1 |
Berberine chloride (TN) | Homo sapiens (human) | Kd | 24.8000 | 1 | 1 |
pioglitazone hydrochloride | Homo sapiens (human) | EC50 | 0.4900 | 1 | 1 |
tetraiodothyroacetic acid | Homo sapiens (human) | EC50 | 2.9600 | 2 | 2 |
tetraiodothyroacetic acid | Homo sapiens (human) | Kd | 1.5000 | 1 | 1 |
honokiol | Homo sapiens (human) | EC50 | 11.8000 | 1 | 1 |
bexarotene | Homo sapiens (human) | EC50 | 0.0390 | 21 | 21 |
bexarotene | Homo sapiens (human) | Kd | 0.2691 | 9 | 15 |
dehydroabietic acid | Homo sapiens (human) | EC50 | 42.0000 | 1 | 1 |
sr 11237 | Homo sapiens (human) | EC50 | 0.0340 | 1 | 1 |
isopimaric acid | Homo sapiens (human) | EC50 | 26.0000 | 1 | 1 |
tretinoin | Homo sapiens (human) | EC50 | 0.6141 | 7 | 8 |
tretinoin | Homo sapiens (human) | Kd | 0.0681 | 6 | 8 |
gw 3965 | Homo sapiens (human) | EC50 | 0.0003 | 2 | 2 |
t0901317 | Homo sapiens (human) | EC50 | 0.0001 | 2 | 2 |
alitretinoin | Homo sapiens (human) | EC50 | 0.0772 | 14 | 14 |
alitretinoin | Homo sapiens (human) | Kd | 0.3115 | 12 | 12 |
sr 11217 | Homo sapiens (human) | EC50 | 0.0860 | 1 | 1 |
calcitriol | Homo sapiens (human) | EC50 | 0.0016 | 1 | 1 |
clothiapine | Homo sapiens (human) | Kd | 15.0100 | 1 | 1 |
nk 104 | Homo sapiens (human) | Kd | 13.3000 | 1 | 1 |
lg 100567 | Homo sapiens (human) | EC50 | 0.1340 | 1 | 1 |
4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid | Homo sapiens (human) | EC50 | 5.0000 | 2 | 2 |
(6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid | Homo sapiens (human) | Kd | 11.0400 | 1 | 1 |
agn 191659 | Homo sapiens (human) | EC50 | 0.0110 | 1 | 1 |
agn 191701 | Homo sapiens (human) | EC50 | 0.2010 | 1 | 1 |
pregna-4,17-diene-3,16-dione | Homo sapiens (human) | EC50 | 100.0000 | 1 | 1 |
valerenic acid | Homo sapiens (human) | EC50 | 27.0000 | 1 | 1 |
lg100754 | Homo sapiens (human) | EC50 | 0.0020 | 1 | 1 |
lg 1506 | Homo sapiens (human) | EC50 | 0.0057 | 3 | 3 |
nrx 194204 | Homo sapiens (human) | EC50 | 0.0002 | 1 | 1 |
nrx 194204 | Homo sapiens (human) | Kd | 0.0004 | 2 | 2 |
agn 194204 | Homo sapiens (human) | Kd | 0.0015 | 1 | 1 |
uab 30 | Homo sapiens (human) | EC50 | 0.8350 | 2 | 2 |
uab 30 | Homo sapiens (human) | Kd | 0.6610 | 5 | 5 |
sr 11302 | Homo sapiens (human) | EC50 | 1.0000 | 1 | 1 |
bms 687453 | Homo sapiens (human) | EC50 | 25.0000 | 1 | 1 |
way 252623 | Homo sapiens (human) | EC50 | 0.0003 | 2 | 2 |
[5-fluoro-1-(4-isopropylbenzylidene)-2-methylinden-3-yl]acetic acid | Homo sapiens (human) | Kd | 2.3800 | 1 | 1 |
1-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)-1h-benzotriazole-5-carboxylic acid | Homo sapiens (human) | EC50 | 0.1430 | 3 | 3 |
Drugs with Other Measurements
Drug | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Publication(s) |
lg 100268 | Homo sapiens (human) | Efficacy | 0.0435 | 2 | 2 |
honokiol | Homo sapiens (human) | ED50 | 11.8000 | 1 | 1 |
bexarotene | Homo sapiens (human) | Activity | 3.7400 | 1 | 1 |
6-(1,2,3,4-tetrahydro-1,1,4,4-tetramethyl-6-naphthyl)-2-naphthalenecarboxylic acid | Homo sapiens (human) | AC50 | 1.0000 | 1 | 1 |
docosahexaenoate | Homo sapiens (human) | ED50 | 50.0000 | 1 | 1 |
alitretinoin | Homo sapiens (human) | AC50 | 0.0070 | 1 | 1 |
alitretinoin | Homo sapiens (human) | Activity | 3.4500 | 1 | 1 |
sr 11217 | Homo sapiens (human) | AC50 | 0.1600 | 1 | 1 |
bigelovin | Homo sapiens (human) | ED50 | 4.9000 | 1 | 1 |
4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid | Homo sapiens (human) | AC50 | 1.0000 | 1 | 1 |
nrx 194204 | Homo sapiens (human) | Efficacy | 0.0440 | 2 | 2 |
Design, synthesis, and biological evaluation of indenoisoquinoline rexinoids with chemopreventive potential.Journal of medicinal chemistry, , Mar-28, Volume: 56, Issue:6, 2013
Design, synthesis and structure-activity relationship of novel RXR-selective modulators.Bioorganic & medicinal chemistry letters, , Mar-22, Volume: 14, Issue:6, 2004
Novel (2E,4E,6Z)-7-(2-alkoxy-3,5-dialkylbenzene)-3-methylocta-2,4,6-trienoic acid retinoid X receptor modulators are active in models of type 2 diabetes.Journal of medicinal chemistry, , Jun-19, Volume: 46, Issue:13, 2003
Design and synthesis of novel RXR-selective modulators with improved pharmacological profile.Bioorganic & medicinal chemistry letters, , Nov-17, Volume: 13, Issue:22, 2003
Design and synthesis of potent retinoid X receptor selective ligands that induce apoptosis in leukemia cells.Journal of medicinal chemistry, , Aug-04, Volume: 38, Issue:16, 1995
Rexinoids isolated from Sophora tonkinensis with a gene expression profile distinct from the synthetic rexinoid bexarotene.Journal of natural products, , Jul-25, Volume: 77, Issue:7, 2014
Identification of a naturally occurring rexinoid, honokiol, that activates the retinoid X receptor.Journal of natural products, , Aug-27, Volume: 73, Issue:8, 2010
Identification of a Vitamin-D Receptor Antagonist, MeTC7, which Inhibits the Growth of Xenograft and Transgenic Tumors Journal of medicinal chemistry, , 04-28, Volume: 65, Issue:8, 2022
Creation of Fluorescent RXR Antagonists Based on CBTF-EE and Application to a Fluorescence Polarization Binding Assay.ACS medicinal chemistry letters, , Jun-10, Volume: 12, Issue:6, 2021
3H-Imidazo[4,5-b]pyridine-6-carboxylic acid derivatives as rexinoids with reduced teratogenicity.Bioorganic & medicinal chemistry letters, , 08-01, Volume: 29, Issue:15, 2019
Tuning Nuclear Receptor Selectivity of Wy14,643 towards Selective Retinoid X Receptor Modulation.Journal of medicinal chemistry, , 02-28, Volume: 62, Issue:4, 2019
Competitive Binding Assay with an Umbelliferone-Based Fluorescent Rexinoid for Retinoid X Receptor Ligand Screening.Journal of medicinal chemistry, , 10-10, Volume: 62, Issue:19, 2019
Natural-Products-Inspired Use of the gem-Dimethyl Group in Medicinal Chemistry.Journal of medicinal chemistry, , 03-22, Volume: 61, Issue:6, 2018
Scaffold hopping from synthetic RXR modulators by virtual screening and MedChemComm, , Aug-01, Volume: 9, Issue:8, 2018
Modeling, Synthesis, and Biological Evaluation of Potential Retinoid X Receptor (RXR)-Selective Agonists: Analogues of 4-[1-(3,5,5,8,8-Pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)ethynyl]benzoic Acid (Bexarotene) and 6-(Ethyl(5,5,8,8-tetrahydronaphthalen-2-Journal of medicinal chemistry, , 10-13, Volume: 59, Issue:19, 2016
Chiral Dihydrobenzofuran Acids Show Potent Retinoid X Receptor-Nuclear Receptor Related 1 Protein Dimer Activation.Journal of medicinal chemistry, , Feb-11, Volume: 59, Issue:3, 2016
Positron emission tomography to elucidate pharmacokinetic differences of regioisomeric retinoid x receptor agonists.ACS medicinal chemistry letters, , Mar-12, Volume: 6, Issue:3, 2015
Conformationally Defined Rexinoids and Their Efficacy in the Prevention of Mammary Cancers.Journal of medicinal chemistry, , Oct-08, Volume: 58, Issue:19, 2015
Methyl-substituted conformationally constrained rexinoid agonists for the retinoid X receptors demonstrate improved efficacy for cancer therapy and prevention.Bioorganic & medicinal chemistry, , Jan-01, Volume: 22, Issue:1, 2014
Methyl substitution of a rexinoid agonist improves potency and reveals site of lipid toxicity.Journal of medicinal chemistry, , Jun-26, Volume: 57, Issue:12, 2014
Discovery of a small molecular compound simultaneously targeting RXR and HADC: design, synthesis, molecular docking and bioassay.Bioorganic & medicinal chemistry letters, , Jul-01, Volume: 23, Issue:13, 2013
Identification of diaryl ether-based ligands for estrogen-related receptor α as potential antidiabetic agents.Journal of medicinal chemistry, , Feb-10, Volume: 54, Issue:3, 2011
Modification at the acidic domain of RXR agonists has little effect on permissive RXR-heterodimer activation.Bioorganic & medicinal chemistry letters, , Sep-01, Volume: 20, Issue:17, 2010
Modification at the Lipophilic Domain of RXR Agonists Differentially Influences Activation of RXR Heterodimers.ACS medicinal chemistry letters, , Dec-09, Volume: 1, Issue:9, 2010
Modeling, synthesis and biological evaluation of potential retinoid X receptor (RXR) selective agonists: novel analogues of 4-[1-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)ethynyl]benzoic acid (bexarotene).Journal of medicinal chemistry, , Oct-08, Volume: 52, Issue:19, 2009
Synthesis and characterization of a new RXR agonist based on the 6-tert-butyl-1,1-dimethylindanyl structure.Bioorganic & medicinal chemistry letters, , Sep-16, Volume: 12, Issue:18, 2002
Synthesis of retinoid X receptor-specific ligands that are potent inducers of adipogenesis in 3T3-L1 cells.Journal of medicinal chemistry, , Feb-25, Volume: 42, Issue:4, 1999
Engineering novel specificities for ligand-activated transcription in the nuclear hormone receptor RXR.Chemistry & biology, , Volume: 5, Issue:1, 1998
Regulation of retinoidal actions by diazepinylbenzoic acids. Retinoid synergists which activate the RXR-RAR heterodimers.Journal of medicinal chemistry, , Dec-19, Volume: 40, Issue:26, 1997
Conformational effects on retinoid receptor selectivity. 2. Effects of retinoid bridging group on retinoid X receptor activity and selectivity.Journal of medicinal chemistry, , Aug-18, Volume: 38, Issue:17, 1995
Design and synthesis of potent retinoid X receptor selective ligands that induce apoptosis in leukemia cells.Journal of medicinal chemistry, , Aug-04, Volume: 38, Issue:16, 1995
Synthesis and structure-activity relationships of novel retinoid X receptor-selective retinoids.Journal of medicinal chemistry, , Sep-02, Volume: 37, Issue:18, 1994
4-[3-(5,6,7,8-Tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)phenyl]benzoic acid and heterocyclic-bridged analogues are novel retinoic acid receptor subtype and retinoid X receptor alpha agonists.Bioorganic & medicinal chemistry letters, , Jun-19, Volume: 10, Issue:12, 2000
Retinoic acid receptor ligands based on the 6-cyclopropyl-2,4-hexadienoic acid.Bioorganic & medicinal chemistry letters, , Jan-20, Volume: 13, Issue:2, 2003
An improved synthesis of the C-linked glucuronide of N-(4-hydroxyphenyl)retinamide.Bioorganic & medicinal chemistry letters, , Sep-02, Volume: 12, Issue:17, 2002
Stereoselective synthesis and receptor activity of conformationally defined retinoid X receptor selective ligands.Bioorganic & medicinal chemistry letters, , Feb-22, Volume: 9, Issue:4, 1999
Engineering novel specificities for ligand-activated transcription in the nuclear hormone receptor RXR.Chemistry & biology, , Volume: 5, Issue:1, 1998
Regulation of retinoidal actions by diazepinylbenzoic acids. Retinoid synergists which activate the RXR-RAR heterodimers.Journal of medicinal chemistry, , Dec-19, Volume: 40, Issue:26, 1997
Discovery of novel retinoic acid receptor agonists having potent antiproliferative activity in cervical cancer cells.Journal of medicinal chemistry, , Jul-05, Volume: 39, Issue:14, 1996
Synthesis and structure-activity relationships of retinoid X receptor selective diaryl sulfide analogs of retinoic acid.Journal of medicinal chemistry, , Aug-30, Volume: 39, Issue:18, 1996
Conformationally defined 6-s-trans-retinoic acid analogs. 3. Structure-activity relationships for nuclear receptor binding, transcriptional activity, and cancer chemopreventive activity.Journal of medicinal chemistry, , Sep-13, Volume: 39, Issue:19, 1996
Conformationally defined 6-s-trans-retinoic acid analogs. 2. Selective agonists for nuclear receptor binding and transcriptional activity.Journal of medicinal chemistry, , Jun-23, Volume: 38, Issue:13, 1995
Synthesis and characterization of a highly potent and effective antagonist of retinoic acid receptors.Journal of medicinal chemistry, , Nov-24, Volume: 38, Issue:24, 1995
Conformational effects on retinoid receptor selectivity. 2. Effects of retinoid bridging group on retinoid X receptor activity and selectivity.Journal of medicinal chemistry, , Aug-18, Volume: 38, Issue:17, 1995
Synthesis and structure-activity relationships of stilbene retinoid analogs substituted with heteroaromatic carboxylic acids.Journal of medicinal chemistry, , Jul-21, Volume: 38, Issue:15, 1995
Synthesis of high specific activity [3H]-9-cis-retinoic acid and its application for identifying retinoids with unusual binding properties.Journal of medicinal chemistry, , Feb-04, Volume: 37, Issue:3, 1994
Conformational effects on retinoid receptor selectivity. 1. Effect of 9-double bond geometry on retinoid X receptor activity.Journal of medicinal chemistry, , Sep-03, Volume: 36, Issue:18, 1993
Competitive Binding Assay with an Umbelliferone-Based Fluorescent Rexinoid for Retinoid X Receptor Ligand Screening.Journal of medicinal chemistry, , 10-10, Volume: 62, Issue:19, 2019
Rexinoids isolated from Sophora tonkinensis with a gene expression profile distinct from the synthetic rexinoid bexarotene.Journal of natural products, , Jul-25, Volume: 77, Issue:7, 2014
Discovery of new LXRβ agonists as glioblastoma inhibitors.European journal of medicinal chemistry, , May-15, Volume: 194, 2020
Liver X receptor (LXR) partial agonists: biaryl pyrazoles and imidazoles displaying a preference for LXRβ.Bioorganic & medicinal chemistry letters, , Jan-15, Volume: 25, Issue:2, 2015
Discovery and structure-guided optimization of tert-butyl 6-(phenoxymethyl)-3-(trifluoromethyl)benzoates as liver X receptor agonists.Bioorganic & medicinal chemistry letters, , Sep-15, Volume: 25, Issue:18, 2015
Discovery of (Journal of medicinal chemistry, , 07-28, Volume: 65, Issue:14, 2022
Discovery of Pan-peroxisome Proliferator-Activated Receptor Modulators from an Endolichenic Fungus, Journal of natural products, , 12-23, Volume: 85, Issue:12, 2022
Identification of a Vitamin-D Receptor Antagonist, MeTC7, which Inhibits the Growth of Xenograft and Transgenic Tumors Journal of medicinal chemistry, , 04-28, Volume: 65, Issue:8, 2022
Conformationally Defined Rexinoids for the Prevention of Inflammation and Nonmelanoma Skin Cancers.Journal of medicinal chemistry, , 11-10, Volume: 65, Issue:21, 2022
[no title available]Journal of medicinal chemistry, , 01-14, Volume: 64, Issue:1, 2021
Competitive Binding Assay with an Umbelliferone-Based Fluorescent Rexinoid for Retinoid X Receptor Ligand Screening.Journal of medicinal chemistry, , 10-10, Volume: 62, Issue:19, 2019
Discovery of 3α,7α,11β-Trihydroxy-6α-ethyl-5β-cholan-24-oic Acid (TC-100), a Novel Bile Acid as Potent and Highly Selective FXR Agonist for Enterohepatic Disorders.Journal of medicinal chemistry, , Oct-13, Volume: 59, Issue:19, 2016
Conformationally Defined Rexinoids and Their Efficacy in the Prevention of Mammary Cancers.Journal of medicinal chemistry, , Oct-08, Volume: 58, Issue:19, 2015
Identification of the first inverse agonist of retinoid-related orphan receptor (ROR) with dual selectivity for RORβ and RORγt.Bioorganic & medicinal chemistry letters, , Nov-15, Volume: 24, Issue:22, 2014
Methyl-substituted conformationally constrained rexinoid agonists for the retinoid X receptors demonstrate improved efficacy for cancer therapy and prevention.Bioorganic & medicinal chemistry, , Jan-01, Volume: 22, Issue:1, 2014
Methyl substitution of a rexinoid agonist improves potency and reveals site of lipid toxicity.Journal of medicinal chemistry, , Jun-26, Volume: 57, Issue:12, 2014
Cytosporone B is an agonist for nuclear orphan receptor Nur77.Nature chemical biology, , Volume: 4, Issue:9, 2008
Ligand recognition by RAR and RXR receptors: binding and selectivity.Journal of medicinal chemistry, , Oct-06, Volume: 48, Issue:20, 2005
Determinants of retinoid X receptor transcriptional antagonism.Journal of medicinal chemistry, , Aug-26, Volume: 47, Issue:18, 2004
Retinoic acid receptor ligands based on the 6-cyclopropyl-2,4-hexadienoic acid.Bioorganic & medicinal chemistry letters, , Jan-20, Volume: 13, Issue:2, 2003
Synthesis and characterization of a new RXR agonist based on the 6-tert-butyl-1,1-dimethylindanyl structure.Bioorganic & medicinal chemistry letters, , Sep-16, Volume: 12, Issue:18, 2002
Enantioselective syntheses of potent retinoid X receptor ligands: differential biological activities of individual antipodes.Journal of medicinal chemistry, , Jul-05, Volume: 44, Issue:14, 2001
sp2-bridged diaryl retinoids: effects of bridge-region substitution on retinoid X receptor (RXR) selectivity.Bioorganic & medicinal chemistry letters, , Jun-19, Volume: 10, Issue:12, 2000
Stereoselective synthesis and receptor activity of conformationally defined retinoid X receptor selective ligands.Bioorganic & medicinal chemistry letters, , Feb-22, Volume: 9, Issue:4, 1999
Regulation of retinoidal actions by diazepinylbenzoic acids. Retinoid synergists which activate the RXR-RAR heterodimers.Journal of medicinal chemistry, , Dec-19, Volume: 40, Issue:26, 1997
Discovery of novel retinoic acid receptor agonists having potent antiproliferative activity in cervical cancer cells.Journal of medicinal chemistry, , Jul-05, Volume: 39, Issue:14, 1996
Synthesis and structure-activity relationships of retinoid X receptor selective diaryl sulfide analogs of retinoic acid.Journal of medicinal chemistry, , Aug-30, Volume: 39, Issue:18, 1996
Identification of the first retinoid X, receptor homodimer antagonist.Journal of medicinal chemistry, , Aug-16, Volume: 39, Issue:17, 1996
Conformationally defined 6-s-trans-retinoic acid analogs. 3. Structure-activity relationships for nuclear receptor binding, transcriptional activity, and cancer chemopreventive activity.Journal of medicinal chemistry, , Sep-13, Volume: 39, Issue:19, 1996
Conformational effects on retinoid receptor selectivity. 2. Effects of retinoid bridging group on retinoid X receptor activity and selectivity.Journal of medicinal chemistry, , Aug-18, Volume: 38, Issue:17, 1995
Synthesis and structure-activity relationships of stilbene retinoid analogs substituted with heteroaromatic carboxylic acids.Journal of medicinal chemistry, , Jul-21, Volume: 38, Issue:15, 1995
Synthesis of high specific activity [3H]-9-cis-retinoic acid and its application for identifying retinoids with unusual binding properties.Journal of medicinal chemistry, , Feb-04, Volume: 37, Issue:3, 1994
Conformational effects on retinoid receptor selectivity. 1. Effect of 9-double bond geometry on retinoid X receptor activity.Journal of medicinal chemistry, , Sep-03, Volume: 36, Issue:18, 1993
sp2-bridged diaryl retinoids: effects of bridge-region substitution on retinoid X receptor (RXR) selectivity.Bioorganic & medicinal chemistry letters, , Jun-19, Volume: 10, Issue:12, 2000
Conformational effects on retinoid receptor selectivity. 2. Effects of retinoid bridging group on retinoid X receptor activity and selectivity.Journal of medicinal chemistry, , Aug-18, Volume: 38, Issue:17, 1995
4-[3-(5,6,7,8-Tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)phenyl]benzoic acid and heterocyclic-bridged analogues are novel retinoic acid receptor subtype and retinoid X receptor alpha agonists.Bioorganic & medicinal chemistry letters, , Jun-19, Volume: 10, Issue:12, 2000
Synthesis and structure-activity relationships of stilbene retinoid analogs substituted with heteroaromatic carboxylic acids.Journal of medicinal chemistry, , Jul-21, Volume: 38, Issue:15, 1995
Synthesis of high specific activity [3H]-9-cis-retinoic acid and its application for identifying retinoids with unusual binding properties.Journal of medicinal chemistry, , Feb-04, Volume: 37, Issue:3, 1994
Design, synthesis and structure-activity relationship of novel RXR-selective modulators.Bioorganic & medicinal chemistry letters, , Mar-22, Volume: 14, Issue:6, 2004
Design and synthesis of novel RXR-selective modulators with improved pharmacological profile.Bioorganic & medicinal chemistry letters, , Nov-17, Volume: 13, Issue:22, 2003
Design and synthesis of fluorinated RXR modulators.Bioorganic & medicinal chemistry letters, , Oct-06, Volume: 13, Issue:19, 2003
Novel (2E,4E,6Z)-7-(2-alkoxy-3,5-dialkylbenzene)-3-methylocta-2,4,6-trienoic acid retinoid X receptor modulators are active in models of type 2 diabetes.Journal of medicinal chemistry, , Jun-19, Volume: 46, Issue:13, 2003
Ligand recognition by RAR and RXR receptors: binding and selectivity.Journal of medicinal chemistry, , Oct-06, Volume: 48, Issue:20, 2005
Design and synthesis of novel RXR-selective modulators with improved pharmacological profile.Bioorganic & medicinal chemistry letters, , Nov-17, Volume: 13, Issue:22, 2003
Enantioselective syntheses of potent retinoid X receptor ligands: differential biological activities of individual antipodes.Journal of medicinal chemistry, , Jul-05, Volume: 44, Issue:14, 2001
Conformationally Defined Rexinoids for the Prevention of Inflammation and Nonmelanoma Skin Cancers.Journal of medicinal chemistry, , 11-10, Volume: 65, Issue:21, 2022
Conformationally Defined Rexinoids and Their Efficacy in the Prevention of Mammary Cancers.Journal of medicinal chemistry, , Oct-08, Volume: 58, Issue:19, 2015
Methyl-substituted conformationally constrained rexinoid agonists for the retinoid X receptors demonstrate improved efficacy for cancer therapy and prevention.Bioorganic & medicinal chemistry, , Jan-01, Volume: 22, Issue:1, 2014
Methyl substitution of a rexinoid agonist improves potency and reveals site of lipid toxicity.Journal of medicinal chemistry, , Jun-26, Volume: 57, Issue:12, 2014
3H-Imidazo[4,5-b]pyridine-6-carboxylic acid derivatives as rexinoids with reduced teratogenicity.Bioorganic & medicinal chemistry letters, , 08-01, Volume: 29, Issue:15, 2019
Mechanism of retinoid X receptor partial agonistic action of 1-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)-1H-benzotriazole-5-carboxylic acid and structural development to increase potency.Journal of medicinal chemistry, , Mar-14, Volume: 56, Issue:5, 2013
RXR Partial Agonist CBt-PMN Exerts Therapeutic Effects on Type 2 Diabetes without the Side Effects of RXR Full Agonists.ACS medicinal chemistry letters, , May-10, Volume: 3, Issue:5, 2012
Enables
This protein enables 21 target(s):
Target | Category | Definition |
transcription cis-regulatory region binding | molecular function | Binding to a specific sequence of DNA that is part of a regulatory region that controls transcription of that section of the DNA. The transcribed region might be described as a gene, cistron, or operon. [GOC:txnOH] |
RNA polymerase II transcription regulatory region sequence-specific DNA binding | molecular function | Binding to a specific sequence of DNA that is part of a regulatory region that controls the transcription of a gene or cistron by RNA polymerase II. [GOC:txnOH] |
RNA polymerase II cis-regulatory region sequence-specific DNA binding | molecular function | Binding to a specific upstream regulatory DNA sequence (transcription factor recognition sequence or binding site) located in cis relative to the transcription start site (i.e., on the same strand of DNA) of a gene transcribed by RNA polymerase II. [GOC:txnOH-2018] |
DNA-binding transcription factor activity, RNA polymerase II-specific | molecular function | A DNA-binding transcription factor activity that modulates the transcription of specific gene sets transcribed by RNA polymerase II. [GOC:txnOH-2018] |
transcription coregulator binding | molecular function | Binding to a transcription coregulator, a protein involved in regulation of transcription via protein-protein interactions with transcription factors and other transcription regulatory proteins. Cofactors do not bind DNA directly, but rather mediate protein-protein interactions between regulatory transcription factors and the basal transcription machinery. [GOC:krc] |
retinoic acid binding | molecular function | Binding to retinoic acid, 3,7-dimethyl-9-(2,6,-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid. [GOC:hjd] |
double-stranded DNA binding | molecular function | Binding to double-stranded DNA. [GOC:elh, GOC:vw] |
DNA-binding transcription factor activity | molecular function | A transcription regulator activity that modulates transcription of gene sets via selective and non-covalent binding to a specific double-stranded genomic DNA sequence (sometimes referred to as a motif) within a cis-regulatory region. Regulatory regions include promoters (proximal and distal) and enhancers. Genes are transcriptional units, and include bacterial operons. [GOC:txnOH-2018] |
nuclear steroid receptor activity | molecular function | Combining with a steroid hormone and transmitting the signal within the cell to initiate a change in cell activity or function. [GOC:signaling, PMID:14708019] |
nuclear receptor activity | molecular function | A DNA-binding transcription factor activity regulated by binding to a ligand that modulates the transcription of specific gene sets transcribed by RNA polymerase II. Nuclear receptor ligands are usually lipid-based (such as a steroid hormone) and the binding of the ligand to its receptor often occurs in the cytosol, which leads to its translocation to the nucleus. [GOC:txnOH-2018, PMID:23457262] |
protein binding | molecular function | Binding to a protein. [GOC:go_curators] |
zinc ion binding | molecular function | Binding to a zinc ion (Zn). [GOC:ai] |
enzyme binding | molecular function | Binding to an enzyme, a protein with catalytic activity. [GOC:jl] |
peptide binding | molecular function | Binding to a peptide, an organic compound comprising two or more amino acids linked by peptide bonds. [GOC:jl] |
identical protein binding | molecular function | Binding to an identical protein or proteins. [GOC:jl] |
nuclear vitamin D receptor binding | molecular function | Binding to a nuclear vitamin D receptor, a nuclear receptor that mediates the action of vitamin D by binding DNA and controlling the transcription of hormone-sensitive genes. [GOC:jl, PMID:12637589] |
sequence-specific DNA binding | molecular function | Binding to DNA of a specific nucleotide composition, e.g. GC-rich DNA binding, or with a specific sequence motif or type of DNA e.g. promotor binding or rDNA binding. [GOC:jl] |
retinoic acid-responsive element binding | molecular function | Binding to a retinoic acid-responsive element, a variable direct repeat of the sequence PuGGTCA spaced by five nucleotides (DR5) found in the promoters of retinoic acid-responsive genes, to which retinoic acid receptors bind. [GOC:jl, GOC:vw, GOC:yaf, PMID:11327309, PMID:19917671] |
DNA binding domain binding | molecular function | Binding to a protein's DNA binding domain (DBD). [PMID:9682036] |
LBD domain binding | molecular function | Binding to a protein's ligand binding domain (LBD) domain, found in nuclear receptors. In general, the LBDs consist of three layers comprised of twelve alpha-helices and several beta-strands that are organized around a lipophilic ligand-binding pocket. [PMID:9682036] |
sequence-specific double-stranded DNA binding | molecular function | Binding to double-stranded DNA of a specific nucleotide composition, e.g. GC-rich DNA binding, or with a specific sequence motif or type of DNA, e.g. promotor binding or rDNA binding. [GOC:dos, GOC:sl] |
Located In
This protein is located in 4 target(s):
Target | Category | Definition |
nucleus | cellular component | A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent. [GOC:go_curators] |
nucleoplasm | cellular component | That part of the nuclear content other than the chromosomes or the nucleolus. [GOC:ma, ISBN:0124325653] |
mitochondrion | cellular component | A semiautonomous, self replicating organelle that occurs in varying numbers, shapes, and sizes in the cytoplasm of virtually all eukaryotic cells. It is notably the site of tissue respiration. [GOC:giardia, ISBN:0198506732] |
cytosol | cellular component | The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes. [GOC:hjd, GOC:jl] |
Part Of
This protein is part of 4 target(s):
Target | Category | Definition |
transcription regulator complex | cellular component | A protein complex that is capable of associating with DNA by direct binding, or via other DNA-binding proteins or complexes, and regulating transcription. [GOC:jl] |
RNA polymerase II transcription regulator complex | cellular component | A transcription factor complex that acts at a regulatory region of a gene transcribed by RNA polymerase II. [GOC:tb] |
chromatin | cellular component | The ordered and organized complex of DNA, protein, and sometimes RNA, that forms the chromosome. [GOC:elh, PMID:20404130] |
receptor complex | cellular component | Any protein complex that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function. [GOC:go_curators] |
Involved In
This protein is involved in 15 target(s):
Target | Category | Definition |
negative regulation of transcription by RNA polymerase II | biological process | Any process that stops, prevents, or reduces the frequency, rate or extent of transcription mediated by RNA polymerase II. [GOC:go_curators, GOC:txnOH] |
positive regulation of thyroid hormone mediated signaling pathway | biological process | Any process that increases the frequency, rate or extent of thyroid hormone mediated signaling pathway. [GOC:hjd] |
hormone-mediated signaling pathway | biological process | The series of molecular signals mediated by the detection of a hormone. [GOC:sm] |
positive regulation of bone mineralization | biological process | Any process that activates or increases the frequency, rate or extent of bone mineralization. [GOC:go_curators] |
positive regulation of transporter activity | biological process | Any process that activates or increases the activity of a transporter. [GOC:mah] |
response to retinoic acid | biological process | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a retinoic acid stimulus. [GOC:sl] |
peroxisome proliferator activated receptor signaling pathway | biological process | The series of molecular signals initiated by binding of a ligand to any of the peroxisome proliferator activated receptors (alpha, beta or gamma) in the nuclear membrane, and ending with the initiation or termination of the transcription of target genes. [GOC:BHF, PMID:18221086] |
mRNA transcription by RNA polymerase II | biological process | The cellular synthesis of messenger RNA (mRNA) from a DNA template by RNA polymerase II, originating at an RNA polymerase II promoter. [GOC:jl, ISBN:0321000382] |
steroid hormone mediated signaling pathway | biological process | The series of molecular signals mediated by a steroid hormone binding to a receptor. [PMID:12606724] |
positive regulation of DNA-templated transcription | biological process | Any process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription. [GOC:go_curators, GOC:txnOH] |
positive regulation of transcription by RNA polymerase II | biological process | Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter. [GOC:go_curators, GOC:txnOH] |
retinoic acid receptor signaling pathway | biological process | The series of molecular signals generated as a consequence of a retinoic acid receptor binding to one of its physiological ligands. [GOC:dgh] |
positive regulation of vitamin D receptor signaling pathway | biological process | Any process that activates or increases the frequency, rate or extent of vitamin D receptor signaling pathway activity. [GOC:BHF, GOC:mah] |
cell differentiation | biological process | The cellular developmental process in which a relatively unspecialized cell, e.g. embryonic or regenerative cell, acquires specialized structural and/or functional features that characterize a specific cell. Differentiation includes the processes involved in commitment of a cell to a specific fate and its subsequent development to the mature state. [ISBN:0198506732] |
anatomical structure development | biological process | The biological process whose specific outcome is the progression of an anatomical structure from an initial condition to its mature state. This process begins with the formation of the structure and ends with the mature structure, whatever form that may be including its natural destruction. An anatomical structure is any biological entity that occupies space and is distinguished from its surroundings. Anatomical structures can be macroscopic such as a carpel, or microscopic such as an acrosome. [GO_REF:0000021] |